|
1
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aljubran AH, Griffin A, Pintilie M and
Blackstein M: Osteosarcoma in adolescents and adults: Survival
analysis with and without lung metastases. Ann Oncol. 20:1136–1141.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferreira CG, de Melo AC and
Nogueira-Rodrigues A: The adolescent and young adult with cancer:
State of the art-epithelial cancer. Curr Oncol Rep. 15:287–295.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Wang L, Fu B, Berman MA, Diallo A
and Dorf ME: TRIM65 regulates microRNA activity by ubiquitination
of TNRC6. Proc Natl Acad Sci USA. 111:6970–6975. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu S, Yin F, Zhang J, Wicha MS, Chang AE,
Fan W, Chen L, Fan M and Li Q: Regulatory roles of miRNA in the
human neural stem cell transformation to glioma stem cells. J Cell
Biochem. 115:1368–1380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheng G: Circulating miRNAs: Roles in
cancer diagnosis, prognosis and therapy. Adv Drug Deliv Rev.
81:75–93. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duncan RE, Sarkadi-Nagy E, Jaworski K,
Ahmadian M and Sul HS: Identification and functional
characterization of adipose-specific phospholipase A2 (AdPLA). J
Biol Chem. 283:25428–25436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hajnal A, Klemenz R and Schafer R:
Subtraction cloning of H-rev107, a gene specifically expressed in
H-ras resistant fibroblasts. Oncogene. 9:479–490. 1994.PubMed/NCBI
|
|
12
|
Nazarenko I, Schafer R and Sers C:
Mechanisms of the HRSL3 tumor suppressor function in ovarian
carcinoma cells. J Cell Sci. 120:1393–1404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siegrist S, Feral C, Chami M, Solhonne B,
Mattei MG, Rajpert-De Meyts E, Guellaen G and Bulle F: hH-Rev107, a
class II tumor suppressor gene, is expressed by post-meiotic
testicular germ cells and CIS cells but not by human testicular
germ cell tumors. Oncogene. 20:5155–5163. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nazarenko I, Kristiansen G, Fonfara S,
Guenther R, Gieseler C, Kemmner W, Schafer R, Petersen I and Sers
C: H-REV107-1 stimulates growth in non-small cell lung carcinomas
via the activation of mitogenic signaling. Am J Pathol.
169:1427–1439. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang S, Ren Z, Han X, Yang J, Shan L, Li
L, Wang B, Zhang Q, Mu T, Chen K, et al: PLA2G16 expression in
human osteosarcoma is associated with pulmonary metastasis and poor
prognosis. PLoS One. 10:e01272362015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wolf NK, Largaespada DA and Moriarity BS:
Coping with cancer genes altered by copy number. Oncotarget.
6:35155–35156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei J, Shi Y, Zheng L, Zhou B, Inose H,
Wang J, Guo XE, Grosschedl R and Karsenty G: miR-34s inhibit
osteoblast proliferation and differentiation in the mouse by
targeting SATB2. J Cell Biol. 197:509–521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang J, Yan YG, Wang C, Zhang SJ, Yu XH
and Wang WJ: MicroRNAs in osteosarcoma. Clin Chim Acta. 444:9–17.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schaefer JS, Montufar-Solis D, Vigneswaran
N and Klein JR: Selective upregulation of microRNA expression in
peripheral blood leukocytes in IL-10-/- mice precedes expression in
the colon. J Immunol. 187:5834–5841. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu J, Zhang Y, Zhang W, Fan L, Wang L,
Liu Y, Liu S, Guo Y, Wang Y, Yi J, et al: MicroRNA-142-5p
contributes to hashimoto's thyroiditis by targeting CLDN1. J Transl
Med. 14:1662016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chaudhuri AD, Yelamanchili SV, Marcondes
MC and Fox HS: Up-regulation of microRNA-142 in simian
immunodeficiency virus encephalitis leads to repression of
sirtuin1. FASEB J. 27:3720–3729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu R, Bi C, Song J, Wang L, Ge C, Liu X
and Zhang M: Upregulation of miR-142-5p in atherosclerotic plaques
and regulation of oxidized low-density lipoprotein-induced
apoptosis in macrophages. Mol Med Rep. 11:3229–3234. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi D, Zhai B, Zheng Y, Ren R, Han M and
Wang X: Transcatheter arterial infusion chemotherapy increases
expression level of miR-142-5p in stage III colorectal cancer.
Indian J Cancer. 52 Suppl 2:e47–e55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui
J, Liu Y, Gao Z, Li J, Shen L and Lu Y: Combination of hsa-miR-375
and hsa-miR-142-5p as a predictor for recurrence risk in gastric
cancer patients following surgical resection. Ann Oncol.
22:2257–2266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Sempere LF, Galimberti F,
Freemantle SJ, Black C, Dragnev KH, Ma Y, Fiering S, Memoli V, Li
H, et al: Uncovering growth-suppressive MicroRNAs in lung cancer.
Clin Cancer Res. 15:1177–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lou K, Chen N, Li Z, Zhang B, Wang X, Chen
Y, Xu H, Wang D and Wang H: MicroRNA-142-5p overexpression inhibits
cell growth and induces apoptosis by regulating FOXO in
hepatocellular carcinoma cells. Oncol Res. 25:65–73. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tu M, Tang J, He H, Cheng P and Chen C:
MiR-142-5p promotes bone repair by maintaining osteoblast activity.
J Bone Miner Metab. 35:255–264. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jaworski K, Ahmadian M, Duncan RE,
Sarkadi-Nagy E, Varady KA, Hellerstein MK, Lee HY, Samuel VT,
Shulman GI, Kim KH, et al: AdPLA ablation increases lipolysis and
prevents obesity induced by high-fat feeding or leptin deficiency.
Nat Med. 15:159–168. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nomura DK, Long JZ, Niessen S, Hoover HS,
Ng SW and Cravatt BF: Monoacylglycerol lipase regulates a fatty
acid network that promotes cancer pathogenesis. Cell. 140:49–61.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee SC, Fujiwara Y and Tigyi GJ:
Uncovering unique roles of LPA receptors in the tumor
microenvironment. Receptors Clin Investig. 2:e4402015.PubMed/NCBI
|
|
33
|
Wang H, Liu W, Wei D, Hu K, Wu X and Yao
Y: Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor
proliferation, migration and invasion of ovarian cancer cell lines.
Oncol Lett. 7:1581–1585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu Z, Ye S, Hu G, Lv M, Tu Z, Zhou K and
Li Q: The RAF-MEK-ERK pathway: Targeting ERK to overcome obstacles
to effective cancer therapy. Future Med Chem. 7:269–289. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sladitschek HL and Neveu PA: The bimodally
expressed microRNA miR-142 gates exit from pluripotency. Mol Syst
Biol. 11:8502015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shrestha A, Mukhametshina RT, Taghizadeh
S, Vasquez-Pacheco E, Cabrera-Fuentes H, Rizvanov A, Mari B,
Carraro G and Bellusci S: MicroRNA-142 is a multifaceted regulator
in organogenesis, homeostasis, and disease. Dev Dyn. 246:285–290.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li L, Liang S, Wasylishen AR, Zhang Y,
Yang X, Zhou B, Shan L, Han X, Mu T, Wang G and Xiong S: PLA2G16
promotes osteosarcoma metastasis and drug resistance via the MAPK
pathway. Oncotarget. 7:18021–18035. 2016.PubMed/NCBI
|
